Toxigenic Corynebacterium diphtheriae Infections in Low-Risk Patients, Switzerland, 2023.

Autor: Urwyler P, Goldenberger D, Grosheintz K, Tarnutzer R, Markstein M, Sucker C, Balestra AM, Merki L, Baumann M, Gürtler N, Martinez AE, von Rotz M, Ivan B, Lang C, Schläepfer P, Keller PM, Wuerfel E, Tschudin-Sutter S

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2025 Jan; Vol. 31 (1), pp. 164-167.

Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms.

Autor: Ragozzino S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Kuehl R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Leuzinger K; Clinical Virology, Laboratory Medicine, University Hospital Basel, University of Basel, Basel, Switzerland., Schläpfer P; Clinical Virology, Laboratory Medicine, University Hospital Basel, University of Basel, Basel, Switzerland., Urwyler P; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Durovic A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Zingg S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., von Rotz M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Battegay M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Widmer AF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland., Hirsch HH; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland.; Clinical Virology, Laboratory Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Transplantation and Clinical Virology, Department Biomedicine, University of Basel, Basel, Switzerland., Bassetti S; Division of Internal Medicine, University Hospital Basel, University Basel, Basel, Switzerland., Tschudin-Sutter S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel, Switzerland. sarah.tschudin@usb.ch.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. sarah.tschudin@usb.ch.

Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Jul 06; Vol. 13 (1), pp. 73. Date of Electronic Publication: 2024 Jul 06.

A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center.

Autor: von Rotz M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Kuehl R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Durovic A; Swiss Tropical and Public Health Institute, Basel, Switzerland., Zingg S; Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland., Apitz A; Employee Health Service, University Hospital Basel, Basel, Switzerland., Wegner F; Division of Clinical Bacteriology and Mycology, University Hospital Basel, University of Basel, Basel, Switzerland.; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland., Seth-Smith HMB; Division of Clinical Bacteriology and Mycology, University Hospital Basel, University of Basel, Basel, Switzerland.; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland., Roloff T; Division of Clinical Bacteriology and Mycology, University Hospital Basel, University of Basel, Basel, Switzerland.; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland., Leuzinger K; Clinical Virology, Laboratory Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Transplantation and Clinical Virology, Department Biomedicine, University of Basel, Basel, Switzerland., Hirsch HH; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.; Clinical Virology, Laboratory Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Transplantation and Clinical Virology, Department Biomedicine, University of Basel, Basel, Switzerland., Kuster S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Battegay M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Mariani L; Department of Neurosurgery, University Hospital Basel, University of Basel, Basel, Switzerland., Schaeren S; Department of Traumatology and Orthopedics, University Hospital Basel, University of Basel, Basel, Switzerland., Bassetti S; Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland., Banderet-Uglioni F; Employee Health Service, University Hospital Basel, Basel, Switzerland., Egli A; Division of Clinical Bacteriology and Mycology, University Hospital Basel, University of Basel, Basel, Switzerland.; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland., Tschudin-Sutter S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. sarah.tschudin@usb.ch.

Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2023 Apr 21; Vol. 12 (1), pp. 38. Date of Electronic Publication: 2023 Apr 21.

A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic.

Autor: Ehrenzeller S; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Durovic A; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Kuehl R; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Martinez AE; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Bielser M; University of Applied Sciences and Arts Northwestern Switzerland FHNW, Olten, Switzerland., Battegay M; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., von Rotz M; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland., Fringer A; Institute of Nursing, School of Health Professions, Zürich University of Applied Sciences ZHAW, Winterthur, Switzerland., Tschudin-Sutter S; Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. sarah.tschudin@usb.ch.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland. sarah.tschudin@usb.ch.

Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Feb 08; Vol. 11 (1), pp. 30. Date of Electronic Publication: 2022 Feb 08.

Possible Reactivation of SARS-CoV-2 in a Patient with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Case Report.

Autor: Dalla Via V; Division of Hematology, Department of Medicine, University Hospital Basel and University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland., von Rotz M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland., Bättig V; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland., Leuzinger K; Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.; Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland., Hirsch HH; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland.; Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.; Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland., Passweg J; Division of Hematology, Department of Medicine, University Hospital Basel and University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland., Stüssi G; Oncological Institute of Italian Switzerland, Bellinzona, Switzerland., Medinger M; Division of Hematology, Department of Medicine, University Hospital Basel and University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland.; Division of Internal Medicine, Department of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.

Publikováno v: SN comprehensive clinical medicine [SN Compr Clin Med] 2021; Vol. 3 (10), pp. 2011-2015. Date of Electronic Publication: 2021 Jul 20.